Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: A phase II study of the Gynecologic Oncology Group

Gynecologic Oncology

Volumn 100, Issue 2, 2006, Pages 349-354

  Sutton, Gregory ^a   Axelrod, Janice H ^b   Bundy, Brian N ^c   Roy, Tapan ^d,j   Homesley, Howard ^e,k   Lee, Roger B ^f,g   Gehrig, Paola A ^h   Zaino, Richard ⁱ  

^a St Vincent Hospitals and Health Services   (United States)

^b WESTERN PENNSYLVANIA HOSPITAL   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g Tacoma General Hospital   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

ⁱ PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^j UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^k Division of Gynecologic Oncology   (United States)

more..

Author keywords

Adjuvant; Clear cell; Endometrium; Papillary serous; Whole abdominal irradiation

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL CANCER; ABDOMINAL HYSTERECTOMY; ABDOMINAL RADIOTHERAPY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TOXICITY; LUNG CANCER; LUNG TOXICITY; NEPHROTOXICITY; PAPILLARY CARCINOMA; PARAAORTIC LYMPH NODE; PELVIS CANCER; PERITONEUM LAVAGE; PRIORITY JOURNAL; RADIATION DOSE; REPRODUCTIVE TOXICITY; SALPINGOOOPHORECTOMY; SIDE EFFECT; SKIN TOXICITY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT REFUSAL; VAGINA CANCER;

ADENOCARCINOMA, CLEAR CELL; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIECTOMY; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 30444459799     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.037     Document Type: Article

References (16)

1. A. Jemal, T. Murray, and E. Ward Cancer statistics CA Cancer J. Clin. 55 2005 10 30
2. B.E. Greer, and A.D. Hamburger Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by whole-abdominal moving strip technique and pelvic boost irradiation Gynecol. Oncol. 16 1983 365 373
3. A.J. Dembo Abdominal radiotherapy in ovarian cancer Cancer 55 1985 2285 2290
4. M. Hendrickson, J. Ross, P. Eifel, A. Martinez, and R. Kempson Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma Am. J. Surg. Pathol. 6 2 1982 93 108
5. G. Sutton, J.H. Axelrod, B.N. Bundy, T. Roy, H.D. Homesley, and J.H. Malfetano Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a Gynecologic Oncology Group study Gynecol. Oncol. 97 3 2005 755 763
6. R.J. Kurman, and R.E. Scully Clear cell carcinoma of the endometrium: an analysis of 21 cases Cancer 37 1976 872 882
7. W.M. Christopherson, R.C. Alberhasky, and P.J. Connelly Carcinoma of the endometrium I. A clinicopathologic study of clear-cell and secretory carcinoma Cancer 49 1982 1511 1523
8. V.M. Abelar, I.B. Vergote, K.E. Kjorstad, and C.G. Trope Clear cell carcinoma of the endometrium Cancer 78 1996 1740 1747
9. A. Malpica, C. Tornos, T.W. Burke, and E.G. Silva Low stage clear-cell carcinoma of the endometrium Am. J. Surg. Pathol. 19 1995 769 774
10. B.G. Ward, R.C. Wright, and K. Free Papillary carcinomas of the endometrium Gynecol. Oncol. 39 1990 347 351
11. E.H. Tay, and B.G. Ward The treatment of uterine papillary serous carcinoma (UPSC): are we doing the right thing? Int. J. Gynecol. Cancer 9 1999 463 469
12. B.A. Goff, D.T. Kato, R.A. Schmidt, M. Ek, and J.A. Ferry Uterine papillary serous carcinoma: patterns of metastatic spread Gynecol. Oncol. 54 1994 264 268
13. J.P. Geisler, H.E. Geisler, M.E. Melton, and M.C. Wiemann What staging surgery should be performed on patients with uterine papillary serous carcinoma? Gynecol. Oncol. 74 1999 465 467
14. R.E. Bristow, F. Asrari, E.L. Trimble, and F.J. Mantz Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-III) disease Gynecol. Oncol. 81 2001 279 286
15. P.S. Craighead, K. Sait, G.C. Stuart, K. Arthur, J. Nation, and M. Duggan Management of aggressive histologic variants of endometrial cancer at the Tom Baker Cancer Center between 1984 and 1994 Gynecol. Oncol. 77 2000 248 253
16. B.M. Sood, J. Jones, and S. Gupta Patterns of failure after multimodality treatment of uterine papillary serous carcinoma Int. J. Radiat. Oncol. Biol. Phys. 57 2003 208 216